CEACAM5 and malignant colon neoplasm: Another immune based approach is to stimulate antigen presenting cells (APCs) with rAAV-encoded antigens such as carcinoembryonic antigen (CEA) as a vaccine for colon cancer; indeed, this approach was shown to reduce the development of colon tumors in mice [43].